Evidence map›Paper›PMID 11311540›Full record

ArticleNeuroscience2001

Pharmacology, distribution and development of muscarinic acetylcholine receptor subtypes in the optic tectum of Rana pipiens.

C M Butt, J R Pauly, L H Wilkins, L P Dwoskin, E A Debski

Open access · greenAbstract read
In one paragraph

Article in Neuroscience, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

C M ButtSchool of Biological Sciences, University of Kentucky, 101 T. H. Morgan Building, Lexington, KY 40506-0225, USA.
J R Pauly
L H Wilkins
L P Dwoskin
E A Debski
University of Kentucky · US

Funding

CHOLINERGIC MODULATION OF THE VISUAL SYSTEMR01EY011913 · NEI · UNIVERSITY OF KENTUCKY · PI DEBSKI, ELIZABETH A · 1997 to 2000
$91k
BEHAVIORAL ECOLOGY AND COMPARATIVE NEUROBIOLOGYT32MH019917 · NIMH · UNIVERSITY OF KENTUCKY · PI PERETZ, BERTRAM · 1994 to 1998
–
NEI NIH HHS EY 11913NEI NIH HHS R01 EY011913NIMH NIH HHS 5T32MH19917NIMH NIH HHS T32 MH019917
6 · The paper itself

Abstract

Visually evoked behaviors mediated by the frog optic tectum require cholinergic activity, but the receptor subtypes through which acetylcholine acts are not yet identified. Using quantitative autoradiography and scintillation spectrometry, we examined the binding of [3H]pirenzepine and [3H]AF-DX 384 in the laminated optic tectum of the frog. In mammalian systems, these substances bind excitatory (m1 and m3 subtypes) and inhibitory (m2 and m4 subtypes) muscarinic acetylcholine receptors, respectively. Pharmacological analyses, including the use of specific muscarinic toxins, confirmed the subtype selectivity of the radioligands in the frog brain. Binding sites for [3H]pirenzepine were distinct from those for [3H]AF-DX 384. In the adult tectum, [3H]pirenzepine demonstrated specific binding in tectal layers 5-9. [3H]Pirenzepine binding was also present in tadpoles as young as stage V, but all sampled stages of tadpole tectum had significantly less binding when compared to adults. Lesioning of the optic nerve had no effect on [3H]pirenzepine binding. Specific [3H]AF-DX 384 binding was found in all layers of the adult tectum. All sampled tadpole stages exhibited binding sites for [3H]AF-DX 384, but the densities of these sites were also significantly higher in adults than they were in developing stages. Short-term lesions of the optic nerve reduced [3H]AF-DX 384 binding in all tectal layers of the deafferented lobe when compared to the afferented one. Long-term lesions decreased [3H]AF-DX 384 sites in both lobes.These results indicate that multiple muscarinic acetylcholine receptor binding sites reside in the frog optic tectum at all stages of development, and their pharmacology resembles that of mammalian m1/m3, m2 and m4 subtypes. Our data indicate that few, if any, of these receptors are likely to be located on retinal ganglion cell terminals. Furthermore, the expression of inhibitory muscarinic subtypes seems to be regulated by different mechanisms than that for excitatory subtypes.

Indexed as

AcetylcholineAnimalsBinding SitesDenervationLarvaMuscarinic AntagonistsNeuronsOptic NerveParasympatholyticsPirenzepineRadioligand AssayRana pipiensReceptors, MuscarinicSuperior ColliculiTritiumVisual PathwaysAcetylcholineAFDX 384Muscarinic AntagonistsParasympatholyticsPirenzepineReceptors, MuscarinicTritium

Identifiers

PMID11311540
PMCPMC2266691
OpenAlexW1995010120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.